Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: A multicenter, randomized trial
✍ Scribed by Frank P. Strietzel; Gloria I. Lafaurie; Gloria R. Bautista Mendoza; Ivan Alajbeg; Slavica Pejda; Lea Vuletić; Rubén Mantilla; Denise P. Falcão; Soraya C. Leal; Ana C. Barreto Bezerra; Simon D. Tran; Henri A. Ménard; Suguru Kimoto; Shaoxia Pan; Rafael A. Martín-Granizo; M. Lourdes Maniegas Lozano; Susan L. Zunt; Cheryl A. Krushinski; Dario Melilli; Giuseppina Campisi; Carlo Paderni; Sonia Dolce; Juan F. Yepes; Liselott Lindh; Meltem Koray; Gonca Mumcu; Sharon Elad; Itai Zeevi; Beatriz C. Aldape Barrios; Rodrigo M. López Sánchez; Ben Z. Beiski; Andy Wolff; Yrjö T. Konttinen
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 178 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Topical antifungal treatments are recommended but rarely used as first‐line therapy for oropharyngeal candidiasis (OPC) in patients with cancer. Miconazole Lauriad 50‐mg mucoadhesive buccal tablet (MBT) Loramyc reportedly delivered rapid and prolonged, effective concentr